Evaluation of the Wilma-SIE virtual screening method in community structure–activity resource 2013 and 2014 blind challenges

Download
  1. (PDF, 1 MB)
  2. Get@NRC: Evaluation of the Wilma-SIE virtual screening method in community structure–activity resource 2013 and 2014 blind challenges (Opens in a new window)
DOIResolve DOI: http://doi.org/10.1021/acs.jcim.5b00278
AuthorSearch for: ; Search for: ; Search for:
TypeArticle
Journal titleJournal of Chemical Information and Modeling
ISSN1549-9596
1549-960X
AbstractProspective assessments of the Wilma-SIE (solvated interaction energy) platform for ligand docking and ranking were performed during the 2013 and 2014 editions of the Community Structure–Activity Resource (CSAR) blind challenge. Diverse targets like a steroid-binding protein, a serine protease (factor Xa), a tyrosine kinase (Syk), and a nucleotide methyltransferase (TrmD) were included. Pose selection was achieved with high precision; in all 24 tests Wilma-SIE top-ranked the native pose among carefully generated sets of decoy conformations. Good separation for the native pose was also observed indicating robustness in pose scoring. Cross-docking was also accomplished with high accuracy for the various systems, with ligand median-RMSD values around 1 Å from the crystal structures. Larger deviations were occasionally obtained due to the rigid-target approach even if multiple target structures were used. Affinity ranking of congeneric ligands after cross-docking was reasonable for three of the four systems, with Spearman ranking coefficients around 0.6. Poor affinity ranking for FXa is possibly due to missing structural domains, which are present during measurements. Assignment of protonation states is critical for affinity scoring with the SIE function, as shown here for the Syk system. Including the FiSH model improved cross-docking but worsened affinity predictions, pointing to the need for further fine-tuning of this newer solvation model. The consistently strong performance of the Wilma-SIE platform in recent CSAR and SAMPL blind challenges validates its applicability for virtual screening on a broad range of molecular targets.
Publication date
LanguageEnglish
AffiliationHuman Health Therapeutics; National Research Council Canada
Peer reviewedYes
NRC numberNRC-HHT-53301
NPARC number21277515
Export citationExport as RIS
Report a correctionReport a correction
Record identifiere7947b1a-1980-4082-804a-d0483b3da018
Record created2016-03-10
Record modified2016-05-09
Bookmark and share
  • Share this page with Facebook (Opens in a new window)
  • Share this page with Twitter (Opens in a new window)
  • Share this page with Google+ (Opens in a new window)
  • Share this page with Delicious (Opens in a new window)